Screening for dysplasia and TP53 mutations in closed rectal stumps of patients with ulcerative colitis or Crohn disease

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 3, 2004, Pages 232-237

  Winther, K V ^a   Bruun, E ^b   Federspiel, B ^b   Guldberg, P ^b   Binder, V ^b   Brynskov, J ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE

Author keywords

Crohn disease; Diversion colitis; Inflammatory bowel disease; Rectal stump; TP53; Ulcerative colitis

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CHILD; CLINICAL ARTICLE; COLON RESECTION; CROHN DISEASE; DISEASE DURATION; DYSPLASIA; ENDOSCOPY; ENTERITIS; EXON; FEMALE; GENE MUTATION; HISTOLOGY; HUMAN; LAVAGE; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RECTOSCOPY; RECTUM; RECTUM BIOPSY; RECTUM MUCOSA; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; COLECTOMY; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; MUTATION; RECTAL NEOPLASMS; RECTUM; SIGMOIDOSCOPY;

EID: 1642283309     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520310008368     Document Type: Article

References (36)

1. Lennard-Jones JE, Morson BC, Ritchie JK, Shove DC, Williams CB. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology 1977;73:1280-9.
2. Cohen Z, Löfberg R, Rutgeerts P. Case presentation: rectal remnant complications. Drugs Today 2000;36 Suppl G:147-51.
3. Rieger N, Collopy B, Fink R, Mackay J, Woods R, Keck J. Total colectomy for Crohn disease. Aust NZ J Surg 1999;69:28-30.
4. Oakley JR, Lavery IC, Fazio VW, Jagelman DG, Weakley FL, Easley K. The fate of the rectal stump after subtotal colectomy for ulcerative colitis. Dis Colon Rectum 1985;28:394-6.
5. Cirincione E, Gorfine SR, Bauer JJ. Is Hartmann's procedure safe in Crohn disease? Report of three cases. Dis Colon Rectum 2000; 4:544-7.
6. Victor DW, Jr, Thompson H, Allan RN, Alexander-Williams J. Cancer complicating defunctioned Crohn disease. Clin Oncol 1982;8:163-5.
7. Freemann HJ. Colorectal cancer complicating Crohn disease. Can J Gastroenterol 2001;4:231-6.
8. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444-51.
9. Harling H, Hegnhøj J, Rasmussen TN, Jarnum S. Fate of the rectum after colectomy and ileostomy for Crohn's colitis. Dis Colon Rectum 1991;34:931-5.
10. Baker WN, Glass RE, Ritchie JK, Aylett SO. Cancer of the rectum following colectomy and ileorectal anastomosis for ulcerative colitis. Br J Surg 1978;65:862-8.
11. Thomas DM, Filipe MI, Smedley FH. Dysplasia and carcinoma in the rectal stump of total colitics who have undergone colectomy and ileo-rectal anastomosis. Histopathology 1989;14:289-98.
12. Adson MA, Cooperman AM, Farrow GM. Ileorectostomy for ulcerative disease of the colon. Arch Surg 1972;104:424-8.
13. Edwards CM, George B, Warren B. Diversion colitis: new light through old windows. Histopathology 1999;34:1-5.
14. Neut C, Guillemot F, Colombel JF. Nitrate-reducing bacteria in diversion colitis. A clue to inflammation? Dig Dis Sci 1997;42: 2577-80.
15. Pouillart PR. Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies. Life Sci 1998;63:1739-60.
16. Melville DM, Jass JR, Morson BC, Pollock DJ, Richman PI, Shepherd NA, et al. Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol 1989;20:1008-14.
17. Griffiths AM, Sherman PM. Colonoscopic surveillance for cancer in ulcerative colitis: a critical review. J Pediatr Gastroenterol Nutr 1997;24:202-10.
18. Yin J, Harpas N, Tong Y, Huang Y, Laurin J, Greenwald BD, et al. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 1993;104:1633-9.
19. Holzmann K, Klump B, Borchard F, Hsieh CJ, Kuhn A, Gaco V, et al. Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis. Int J Cancer 1998;76:1-6.
20. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994;107:369-78.
21. Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory bowel disease. Cancer Res 2000;60:3333-7.
22. Lang SM, Stratakis DF, Heinzlmann M, Heldwein W, Wiebecke B, Loeschke K. Molecular screening of patients with long-standing extensive ulcerative colitis: detection of p53 and Ki-ras mutations by single strand conformation polymorphism analysis and differential hybridization in colonic lavage fluid. Gut 1999; 44:822-5.
23. Maratka Z. Terminology, definitions and diagnostic criteria in digestive endoscopy. English revision. 2nd ed. In: Colin-Jones DG, editor. Englewood, NJ: Normed Verlag; 1989.
24. Binder V. A comparison between clinical state, macroscopic and microscopic appearances of the rectal mucosa, and cytological picture of mucosal exudate in ulcerative colitis. Scand J Gastroenterol 1970;5:627-32.
25. Jenkins D, Balsitis M, Gallivan S, Dixon MF, Gilmour HM, Shepherd NA, et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol 1997;50:93-105.
26. Morson BS, Dawson IMP. Biopsy diagnosis of inflammatory bowel disease. In: Gastrointestinal pathology. Oxford: Blackwell; 1979. p. 551-62.
27. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
28. Guldberg P, Nedergaard T, Nielsen HJ, Olsen AC, Ahrenkiel V. Single-step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer. Hum Mutat 1997;9:348-55.
29. Navratil E, Stettler C, Paul G, Vilotte J, Vissuzaine C, Mignon M, et al. Assessment of dysplasia, mucosal mucins, p53 protein expression, and DNA content in ulcerative colitis patients with colectomy and ileorectal anastomosis. Scand J Gastroenterol 1995;30:361-6.
30. Löfberg R, Leijonmarck CE, Broström O, Hellers G, Tribukait B, Ost A. Mucosal dysplasia and DNA content in ulcerative colitis patients with ileorectal anastomosis. Follow-up study in a defined patient group. Dis Colon Rectum 1991;34:566-71.
31. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta analysis. Gut 2001;48:526-35.
32. Geraghty JM, Talbot IC. Diversion colitis: histological features in the colon and rectum after defunctioning colostomy. Gut 1991; 32:1020-3.
33. Warren BF, Shepherd NA. Diversion proctocolitis. Histopathology 1992;21:91-3.
34. Roe AM, Warren BF, Brodribb AJ, Brown C. Diversion colitis and involution of the defunctioned anorectum. Gut 1993;34: 382-5.
35. Warren BF, Shepherd NA, Bartolo DC, Bradfield JW. Pathology of the defunctioned rectum in ulcerative colitis. Gut 1993;34: 514-6.
36. Edwards CM, George BD, Jewell DP, Warren BF, Mortensen NJ, Kettlewell MG. Role of a defunctioning stoma in the management of large bowel Crohn's disease. Br J Surg 2000;87:1063-6.